Alkermes

Alkermes

ALKS
Dublin, Ireland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile
Market Cap: $7.5BPipeline: 92 drugs (35 Phase 3)Founded: 1987HQ: Dublin, Ireland

Overview

Alkermes plc is a fully integrated, global biopharmaceutical company headquartered in Dublin, Ireland with significant U.S. operations, specializing in the discovery, development, and commercialization of innovative medicines for complex psychiatric and neurological disorders. The company applies deep neuroscience expertise to address traditionally overlooked therapeutic areas including addiction, serious mental illness, and sleep disorders, operating with a patient-inspired approach across the entire value chain from discovery through manufacturing and commercialization.

Small Molecules

Pipeline

92
92 drugs in pipeline35 in Phase 3
DrugIndicationStageWatch
Naltrexone for extended-release injectable suspension + Oral...Opioid-Related DisordersApproved
XR-NTX 380 mg, intramuscular injection + Placebo intramuscul...Alcohol Use DisorderApproved
Aripiprazole LauroxilSchizophreniaApproved
VIVITROL 380 mg + PlaceboAlcohol DependenceApproved
Aripiprazole LauroxilSchizophreniaApproved